Press Releases

Our latest happenings and recent highlights.

For media inquiries, please contact: daniel.salvo@omniabio.com

Featured

OmniaBio Inc. Awarded Drug Establishment License (DEL) by Health Canada, Certifying Canada’s Largest Cell & Gene Therapy CDMO

HAMILTON & TORONTO ONTARIO – December 23, 2025 – OmniaBio Inc., Canada’s largest cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), today announced that Health Canada has awarded the company a Drug Establishment License (DEL), confirming the maturity and compliance of its Good Manufacturing Practices (GMP). Secured less than one year after...

Press Releases

Invest Ontario supports new biomanufacturing facility in Hamilton

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation...